Z79.62 - Long term (current) use of immunosuppressant
- Applicable to Long term (current) use of immunosuppressant
- The 2025 edition of ICD10-CM Z79.62 became effective on October 1, 2024.
- This is the American ICD10-CM version of Z79.62 - other international versions of ICD10 Z79.62 may differ.
- Z79.62 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Z79.62 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- Z79.62 - Long term (current) use of immunosuppressant
- Z79.62 - Long term (current) use of immunosuppressant
- Z79.620 - Long term (current) use of immunosuppressive biologic
- Z79.621 - Long term (current) use of calcineurin inhibitor
- Z79.622 - Long term (current) use of Janus kinase inhibitor
- Z79.623 - Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
- Z79.624 - Long term (current) use of inhibitors of nucleotide synthesis
The following codes above Z79.62 contain annotation back-references that may be applicable to Z79.62:
Chapter: Z00-Z99 Factors influencing health status and contact with health services
Category: Z79 Long term (current) drug therapy
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com